Considerations for Statin Therapy in Patients with COVID‐19

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

(2020) Wen Zhang et al.   CLINICAL IMMUNOLOGY

Are certain drugs associated with enhanced mortality in COVID-19?

(2020) M R Goldstein et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection

(2020) David S. Fedson et al.   mBio

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

(2020) Chaomin Wu et al.   JAMA Internal Medicine

Molecular immune pathogenesis and diagnosis of COVID-19

(2020) Xiaowei Li et al.   Journal of Pharmaceutical Analysis

Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome*

(2019) Angela J. Rogers et al.   CRITICAL CARE MEDICINE

Severe community-acquired pneumonia: current management and future therapeutic alternatives

(2018) Jose Garnacho-Montero et al.   Expert Review of Anti-Infective Therapy

Reply to “Statins may decrease the Fatality Rate of MERS Infection”

(2015) Allison L. Totura et al.   mBio

Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection: FIG 1 

(2015) Shu Yuan   mBio

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

(2015) Allison L. Totura et al.   mBio

Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway

(2014) Xiao Yuan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Effect of Statin Therapy on Mortality in Patients With Ventilator-Associated Pneumonia

(2013) Laurent Papazian   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival

(2013) M. L. DeDiego et al.   JOURNAL OF VIROLOGY

Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study*

(2011) Demosthenes Makris et al.   CRITICAL CARE MEDICINE

Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers

(2009) Murali Shyamsundar et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV

(2008) Timothy Sheahan et al.   PLoS Pathogens